1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Immunomonitoring: new trials by email Literature Review of Immunomonitoring trials Research Report on Immunomonitoring
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Trial of IMA950 Multi-peptide Vaccine Plus Poly-ICLC in Glioblastoma IMA 950, Poly ICLC, Immunomonitoring - CNS Tumor, Adult | Phase 1 / Phase 2 | Completed | University Hospital, Geneva | 19 | 2013-08-01 | 2016-04-20 |
Central Nervous System Neoplasms (1) · Glioblastoma (1)
University Hospital, Geneva (1)
Switzerland (1)
Pierre-Yves Dietrich, Professor (1)